Medistim ASA MEDI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- NOK 276.00
- Day Range
- NOK 277.00–288.00
- 52-Week Range
- NOK 186.50–292.00
- Bid/Ask
- NOK 268.00 / NOK 286.00
- Shares Outstanding
- 18.28M
- Market Cap
- NOK 5.14B
- Volume/Avg
- 33,381 / 16,214
Key Statistics
- Price/Earnings (Normalized)
- 31.45
- Price/Sales
- 6.90
- Dividend Yield (Trailing)
- 2.85%
- Dividend Yield (Forward)
- 2.85%
- Dividend Payment Schedule
- May
- Total Yield
- 2.85%
Company Profile
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 159
- Website
- https://www.medistim.com
Valuation
|
Metric
|
MEDI
|
|---|---|
Price/Earnings (Normalized) | 31.45 |
Price/Book Value | 12.63 |
Price/Sales | 6.90 |
Price/Cash Flow | 25.22 |
Price/Earnings
MEDI
Financial Strength
|
Metric
|
MEDI
|
|---|---|
Quick Ratio | 1.88 |
Current Ratio | 3.15 |
Interest Coverage | — |
Quick Ratio
MEDI
Profitability
|
Metric
|
MEDI
|
|---|---|
Return on Assets (Normalized) | 27.24% |
Return on Equity (Normalized) | 37.76% |
Return on Invested Capital (Normalized) | 34.50% |
Return on Assets
MEDI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|tHtJD&G | LOCK|tZyD | $181B | |||
| Medtronic PLC
MDT
| LOCK|N&>y@Zr | LOCK|<^&> | $121B | |||
| Stryker Corp
SYK
| LOCK|WJrY^H&w | LOCK|Y& | $113B | |||
| Boston Scientific Corp
BSX
| LOCK|&B&@LH | LOCK|!!DRR | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&?rH%<%p | LOCK|@<>Pv | $50B | |||
| DexCom Inc
DXCM
| LOCK|XQ>wx$< | LOCK|z!&R | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Vy>FY< | LOCK|ZK | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|l%< | LOCK|!h< | $25B | |||
| Steris PLC
STE
| LOCK|g#wX!< | LOCK|%K>r | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^@VvJ#!N | LOCK|%f | $18B |
United States